| Trial name or title | Comparison of varenicline and placebo for smoking cessation in schizophrenia |
| Methods | Randomised double‐blind placebo‐controlled trial |
| Participants | 44 smokers with schizophrenia |
| Interventions | 12 weeks varenicline 1.0 mg x 2/day vs placebo |
| Outcomes | PPA at 12 weeks, neuropsychiatric symptoms |
| Starting date | November 2007 |
| Contact information | E Weiner |
| Notes |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.